Insights › Market reaction

Why SELLAS Life Sciences Group (SLS) Stock Rose 2.03% in 10 Minutes on Nov 20, 2026

MoveSurge measured three earlier SELLAS Life Sciences Group headlines with an attributed reaction between Aug 22, 2026 and Nov 19, 2026. The largest was +4.05% in 10 minutes, on Oct 28, 2026.

Published in ET: Feed time in ET: Company news SLS +2.03% in 10 min after the headline
  • SLS rose 2.03% in the 10 minutes after the 14:12:46 ET headline, from $13.55 to $13.82.
  • The move kept building after the first minute: +0.46% at one minute, +2.03% at 10 minutes.
Market reaction bar chart for SELLAS Life Sciences Group: real price moves following the headline.
Real observed market reaction — release → +1m → +10m. Validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
SLS 13.55 13.55 13.61 13.82 +0.46% +2.03%

SELLAS Life Sciences Group (SLS) shares rose 2.03% in the 10 minutes after this headline reached the MoveSurge news feed at 14:12:46 ET on Friday, November 20, 2026: “Sellas Life Sciences says galinpepimut-S met the Phase 3 REGAL trial’s primary endpoint, reducing death risk by 41% in AML patients in second remission”

SLS in the first 10 minutes

From a reference price of $13.55 just before the headline, the stock was up 0.46% after one minute and up 2.03%, at $13.82, after 10 minutes. The move kept building after the first minute.

Other SLS headlines on November 20, 2026

  • 16:01 ET: “SELLAS Life Sciences closes public offering of 13,269,231 shares and confirms full exercise of underwriters’ option” (-0.21% in 10 minutes)

Earlier SLS headlines and the measured reaction

MoveSurge measured three earlier SELLAS Life Sciences Group headlines with an attributed reaction between Aug 22, 2026 and Nov 19, 2026. The largest was +4.05% in 10 minutes, on Oct 28, 2026.

  1. Nov 19, 2026, 09:33 ET: “SELLAS Life Sciences prices a $150 million stock sale at a steep discount” (+1.01% in 10 minutes)
  2. Nov 19, 2026, 06:52 ET: “SELLAS Life Sciences prices a $150 million stock sale at a steep discount” (+3.06% in 10 minutes)
  3. Oct 28, 2026, 08:35 ET: “SELLAS Life Sciences says its Phase 3 REGAL trial of galinpepimut-S (GPS) for acute myeloid leukemia has reached its 80th event” (+4.05% in 10 minutes)

SELLAS Life Sciences Group at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$3.03 billion (as of Nov 20, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved SELLAS Life Sciences Group stock on November 20, 2026?

At 14:12:46 ET, this headline crossed: “Sellas Life Sciences says galinpepimut-S met the Phase 3 REGAL trial’s primary endpoint, reducing death risk by 41% in AML patients in second remission”. The stock rose 2.03% in the next 10 minutes.

How far did SLS move after the headline?

From $13.55 just before the headline to $13.82 10 minutes later, a +2.03% move.

What else has moved SLS stock recently?

The two largest measured reactions before November 20, 2026: Oct 28, 2026, SELLAS Life Sciences says its Phase 3 REGAL trial of galinpepimut-S (GPS) for acute myeloid leukemia has reached its 80th event (+4.05% in 10 minutes); Nov 19, 2026, SELLAS Life Sciences prices a $150 million stock sale at a steep discount (+3.06% in 10 minutes).

Sources

Follow SLS live

The live feed pairs breaking headlines with measured price moves. Build a watchlist of stocks you own and choose whether matching news reaches your WhatsApp.

Open the live feed See portfolio WhatsApp alerts
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.